https://www.selleckchem.com/pr....oducts/bgb-15025.htm
The prognosis of patients with recurrent HCC may be improved by liver resection combined with prior lenvatinib therapy. The prognosis of patients with recurrent HCC may be improved by liver resection combined with prior lenvatinib therapy. Direct-acting antiviral (DAA) therapy regimens are highly effective at eliminating hepatitis C virus (HCV) infection but rates of sustained virologic response (SVR) are lower in patients with decompensated cirrhosis or hepatocellular carcinoma. Since many of these patients will be referred for liver
Curtir
Comentario
Compartilhar
